CCA CATO Associate Protocol Development & Study Design

Question 1

Which section of a clinical trial protocol defines the scientific rationale and purpose of the study?

Accepted Answer

Background and Introduction

Answer

The Background and Introduction section provides the scientific rationale, prior research, and purpose that justify conducting the study.

Question 2

What is the primary purpose of inclusion and exclusion criteria in a clinical trial protocol?

Accepted Answer

To define the target study population and ensure participant safety

Answer

Inclusion and exclusion criteria define who may participate, ensuring the study population matches the scientific objectives and that vulnerable or at-risk individuals are appropriately protected.

Question 3

A Phase II clinical trial is primarily designed to:

Accepted Answer

Assess preliminary efficacy and dosing in patients with the target disease

Answer

Phase II trials focus on evaluating preliminary efficacy, determining optimal dosing, and further characterizing safety in patients who have the disease being studied.

Question 4

What is the purpose of a protocol synopsis?

Accepted Answer

To provide a concise summary of the key elements of the study protocol

Answer

A protocol synopsis is a condensed summary of the most critical protocol elements, often used for IRB/IEC submissions, feasibility assessments, or internal reviews.

Question 5

In a randomized controlled trial (RCT), what does 'blinding' primarily aim to prevent?

Accepted Answer

Bias in outcome assessment and participant behavior

Answer

Blinding prevents knowledge of treatment assignment from influencing participant behavior or outcome assessors' evaluations, thereby reducing bias.

(CCA) CATO Certified Associate Practice Test

(CCA) CATO Certified Associate Practice Test

CCA CATO Associate Protocol Development & Study Design